phosphorylethanolamine has been researched along with Leucocythaemia in 2 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhakshinamoorthy, S | 1 |
| Dinh, NT | 1 |
| Skolnick, J | 1 |
| Styczynski, MP | 1 |
| Adebodun, F | 1 |
| Post, JF | 1 |
2 other studies available for phosphorylethanolamine and Leucocythaemia
| Article | Year |
|---|---|
Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemia.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Ethanolamines; Humans; Jurka | 2015 |
31P NMR characterization of cellular metabolism during dexamethasone induced apoptosis in human leukemic cell lines.
Topics: Adenosine Triphosphate; Apoptosis; Dexamethasone; Ethanolamines; Humans; Hydrogen-Ion Concentration; | 1994 |